Table 2. Clinical data for AML patients.
| No. | Age (y/sex) | Status | Cytogenetics | Source | Blasts (%) | CD34a (%) |
|---|---|---|---|---|---|---|
| 1 | 71/F | New | 46,XX | PB | > 90 | 98.9 |
| 2 | 76/M | New | Complex | PB | 28.8 | 92.3 |
| 3 | 52/M | New | 46,XY | BM | 79.2 | 72.2 |
| 4 | 54/M | New | 46,XX,t(8;21)(q22;q22) | BM | 78.4 | 82.9 |
| 5 | 58/M | New | 46,XY | BM | > 90 | 1.3 |
| 6 | 68/M | New | Complex | PB | 34 | NA |
| 7 | 69/M | New | Complex | PB | 40 | NA |
| 8 | 38/F | New | 46,XX | BM | 84.8 | 2.9 |
| 9 | 66/M | New | 46,XY,del(7q) | BM | 26 | 53.0 |
| 10 | 84/F | New | Complex | PB | 60 | NA |
| 11 | 86/M | New | Complex | BM | 48 | 87.0 |
| 12 | 58/M | Relapse | 46,XY | PB | 84 | 0.2 |
| 13 | 87/F | Relapse | 46,XX,inv(16)(p13.1;q22),add(18)(q21) | BM | 60 | 7.0 |
Abbreviations: BM, bone marrow; NA, not analyzed; PB, peripheral blood.
a
The percentage of CD34+ cells was determined by flow cytometry in isolated bone marrow mononuclear cells or peripheral blood mononuclear cells.